Back to Journals » Vascular Health and Risk Management » Volume 14

Clinical potential of canagliflozin in cardiovascular risk reduction in patients with type 2 diabetes

Total article views   Abstract views HTML views PDF downloads Totals
1,650 Dovepress* 1,287 145+ 351 1,432
PubMed Central* 0 218 106 218
Totals 1,287 363 457 1,650
*Since 7 December 2018
+Since July 2016

View citations on PubMed Central and Google Scholar